Scholars Central

Case reportPublished 4 Nov 2021

Inflammation Indexes Pretreatment Associated with Overall Survival and the Response to Nimotuzumab in Patients with Head and Neck Cancer Newly Diagnosed

Authors: Lisania Reyes Espinosa, Tania Crombet Ramos, Agustín Lage Dávila, Carmen Elena Viada González

Head and Neck Cancer Research

Volume 6 · Issue 5 · Pages 1–7

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Abstract Purpose: Neutrophil-lymphocyte ratio (NLR), platelet- lymphocyte ratio (PLR) and systemic immune-inflammation index (SII) are three inflammation indexes based on neutrophil (N), lymphocyte (L) and platelet (P) counts reported to be prognostic and predictive factors in several solid tumours. We aimed to investigate its association with overall survival (OS) and the response to treatment in head and neck squamous cell carcinoma (HNSCC). Methods: A total of 427 newly diagnosed HNSCC patients treated with nimotuzumab (group 1) or radiotherapy (group 2) was enrolled. NLR (NLR=N/L), PLR (PLR=P/L) and SII (SII=N x P/L) were calculated based on the data obtained before treatment. The cut-off value for every index was determined using the Package ‘bhm’ in R 3.5.0 software. Kaplan–Meier method was used to analyse the association of three indexes with OS and the response to treatment. All statistical analyses were carried out using SPSS version 25 software. Differences were considered statistically significant when p<0.05. Results: Kaplan Meier analyses revealed that higher NLR, PLR and SII correlated significantly with poorer OS (p=0.002; p=0.001; p=0.000 respectively) in nimotuzumab treated patients. Patients with low inflammation index before treatment that was subsequently treated with nimotuzumab had a longer survival advantage than those in the group treated with radiotherapy. Keywords Neutrophil lymphocyte ratio; Platelet lymphocyte ratio; Systemic immune inflammation index; Head and neck squamous cell carcinoma; Overall survival; Nimotuzumab

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Head and Neck Cancer Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHead and Neck Cancer Research
  • SubjectOncology & Cancer
  • SubjectENT & Otolaryngology
  • BylineArticles whose byline prints “Lisania Reyes Espinosa”
  • BylineArticles whose byline prints “Tania Crombet Ramos”
  • BylineArticles whose byline prints “Agustín Lage Dávila”
  • BylineArticles whose byline prints “Carmen Elena Viada González”